Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease
出版年份 2022 全文链接
标题
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease
作者
关键词
-
出版物
Journal of Parkinsons Disease
Volume 12, Issue 4, Pages 1155-1167
出版商
IOS Press
发表日期
2022-04-15
DOI
10.3233/jpd-212989
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
- (2021) Argonde C. Harten et al. Alzheimers & Dementia
- Parkinson disease-associated cognitive impairment
- (2021) Dag Aarsland et al. Nature Reviews Disease Primers
- Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
- (2020) David J. Irwin et al. ANNALS OF NEUROLOGY
- Amyloid-β and tau biomarkers and clinical phenotype in dementia with Lewy bodies
- (2020) Daniel Ferreira et al. NEUROLOGY
- Multimodal in vivo and postmortem assessments of tau in Lewy body disorders
- (2020) David G. Coughlin et al. NEUROBIOLOGY OF AGING
- Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
- (2019) Leslie M. Shaw et al. CLINICAL BIOCHEMISTRY
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers
- (2019) Tessandra Stewart et al. JOURNAL OF ALZHEIMERS DISEASE
- Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
- (2019) Kaj Blennow et al. Scientific Reports
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
- (2018) Tanya Simuni et al. MOVEMENT DISORDERS
- CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders
- (2018) David J. Irwin et al. NEUROLOGY
- Finding useful biomarkers for Parkinson’s disease
- (2018) Alice S. Chen-Plotkin et al. Science Translational Medicine
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
- (2018) Kenneth Marek et al. Annals of Clinical and Translational Neurology
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
- (2017) Chelsea Caspell-Garcia et al. PLoS One
- Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies
- (2016) A W Lemstra et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
- (2016) Yosef Berlyand et al. PLoS One
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
- (2015) Daniel Weintraub et al. MOVEMENT DISORDERS
- Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review
- (2015) Katherine Leaver et al. NEUROPSYCHOLOGY REVIEW
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- The epidemiology of dementia associated with Parkinson disease
- (2009) Dag Aarsland et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More